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Background: Chronic kidney disease (CKD) is being increasingly recognized as a leading public health problem.
However, there are limited data available with respect to prevalence of CKD in Pakistan, a developing South Asian
country. The study presents the baseline findings of prevalence and risk factors for adult kidney disease in a
Pakistani community cohort.
Methods: A total of 667 households were enrolled between March 2010 and August 2011 including 461 adults,
aged 15 and older. Mild kidney disease was defined as estimated Glomerular Filtration Rate (eGFR) ≥60 ml/min
with microalbuminuria ≥ 30 mg/dl and moderate kidney disease was defined as eGFR <60 ml/min (with or without
microalbuminuria).
Results: The overall prevalence of kidney disease was 16.6% with 8.6% participants having mild kidney disease
and 8% having moderate kidney disease. Age was significantly associated with kidney disease (p < 0.0001). The
frequency of diabetes, hypertension and smoking differed significantly among the three groups, i.e., no kidney
disease, mild kidney disease and moderate kidney disease.
Conclusion: Our study results suggest that the burden of kidney disease in this population is found considerable
and comparable to neighboring developing countries. We believe that these results have critical implications on
health and economics of these countries and due to the epidemic of diabetes, hypertension, cardiovascular
disease, smoking and association with worsening poverty, further rapid growth is expected. There is an urgent
need for early recognition and prevention strategies based on risk factors and disease trends determined through
longitudinal research.
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Non-communicable diseases (NCDs) present a significant
global health challenge in the current century and have
replaced communicable diseases as the most common
causes of morbidity and premature mortality worldwide
[1]. Initially, four NCDs (cardiovascular disease, cancers,
chronic respiratory diseases and diabetes) were prioritized
in the Global NCD Action Plan [2] endorsed by the World
Health Assembly in 2008 but systematic reviews of
various population based studies have now revealed* Correspondence: ashar.email@gmail.com
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unless otherwise stated.the significance of chronic kidney disease as a separate en-
tity requiring emphasis on prevention, early detection and
treatment [3,4].
In developing countries including Pakistan, the burden
of CKD is growing [5] and is exacerbated due to poor
community awareness, a disproportionately higher bur-
den of known CKD risk factors and poor access to renal
replacement therapy [6]. In resource restricted settings,
overcoming this scenario becomes further complex due
to insufficient community-based data that could help
with targeted prevention. Recent population based studies
[7-9] from Bhopal, India found an incidence rate of 150
cases of end stage renal disease per one million population
(p.m.p). There is no incidence data for kidney diseasetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Pakistan conducted on 300 adults ages 30 years and above
showed some degree of reduced glomerular filtration rate
(GFR) in 25.3% of the screened population, with 5%
having a GFR <60 ml/min, [10] whereas an earlier
survey showed that approximately 15% to 20% of screened
adults 40 years of age or older had a reduced esti-
mated GFR <60 ml/min [11,12].
The Indus Hospital Community Cohort (IHCC) was
established in 2010 with the objective of establishing a
unique ‘Framingham-like’ [13] Pakistani cohort to inves-
tigate the prevalence and risk factors for hypertension,
obesity, diabetes, coronary artery disease, kidney disease
and hepatitis B and C infection in a multi-ethnic, middle
to low income population. The paper highlights the
baseline findings of kidney disease in the adult cohort
population, including prevalence and risk factors for
kidney disease.
Methods
The Indus Hospital is located in Karachi, Pakistan, a
densely populated city with a population of over 20 million.
The catchment areas population is approximately 2.5
million and for the baseline cross-sectional, two admi-
nistrative areas from Indus Hospital's catchment popula-
tion were chosen for enrolment of a random selection of
cohort households. Six hundred and sixty-seven house-
holds were enrolled between March 2010 and August
2011 including 461 adults. Detailed methodology of the
cohort have been published elsewhere [14].
Study sample and design
The baseline survey included questionnaires, anthropomet-
ric measurements, physical examination as well as ultra-
sound and laboratory assessment. Apart from questions
directly related to kidney disease, questions regarding fam-
ily as well as personal history of diabetes, hypertension,
coronary heart disease, hyperlipidemia, and stroke were
also asked. Information on smoking, regular exercise, alco-
hol intake, dietary habits including extra-salt or fat intake
were also asked. Ultrasound examination of the kidneys
and urinary bladder were performed and the size of
kidneys and presence of stones and cysts were noted.
Laboratory tests: Serum creatinine was measured using
Kinetic Colorimetric Assay in alkaline medium on Hitachi
902 (Japan). The glomerular filtration rate (GFR) was
estimated using the new 4-variable Modification of Diet in
Renal Disease (MDRD) equation as follows:
GFR ¼ 186 serum Cr mg=dl½ ð Þ‐1:154  age‐0:203
 0:742 if femaleð Þ
Urine for microalbumin was measured using Solid
Phase Sandwich Immunometric Assay on NycocardReader II (Norway). Mild kidney disease was defined as
eGFR ≥60 ml/min with microalbuminuria ≥30 mg/dl and
moderate kidney disease was defined as eGFR <60 ml/min
(with or without microalbuminuria).
Blood sugar random (BSR) was measured using En-
zymatic Colorimetric without deproteination on Randox
RX Imola (Japan). The glycated hemoglobin (HbA1c)
levels were measured by high performance liquid
chromatography on D-10 Hemoglobin Testing System
(France). As per American Diabetes Association 2010
recommendations, [15] any participant having HBA1C ≥
6.5% or BSR ≥ 200 mg/dl or taking anti-hyperglycemic
agent was labeled as a diabetic. Participants were tagged
as having increased risk of diabetes if their HBA1C
level was between 5.7% – 6.4% without anti-hyperglycemic
agent.
Systolic and diastolic blood pressures were measured by
using an automatic oscillometric method in the sitting
position after at least five minutes rest. Measurement was
performed thrice, and the mean of the readings was used
in the analysis. Hypertension was classified on the
basis of cut-off set by Joint National Commission Re-
port 7 (JNC7) [16] and participants having systolic blood
pressure level ≥ 140 mm Hg, diastolic blood pressure level
of ≥ 90 mm Hg or taking anti-hypertensive agent were
labeled as hypertensive.
Body Surface Area (BSA) was calculated according to
the Dubois and Dubois formula:
BSA m2
  ¼ 0:20247 height mð Þ0:725
 weight kgð Þ0:425:
Body mass index (BMI) was derived by dividing weight
(in kg) by height squared (in m2). Abnormal BMI level
was set as ≥ 25 kg/m2 both in males and females.
The serum levels of total cholesterol and high-density
lipoprotein (HDL) cholesterol were determined enzymati-
cally on Randox RX Imola (Japan). The participants were
considered to have dyslipidemia if the total cholesterol
level was >200 mg/dl, HDL cholesterol level <40 mg/dl or
they were taking anti-hyperlipidemic agents.
Statistical analysis
The data was entered and analyzed using SPSS version 17.
Shapiro Wilk’s test was applied to check the normality of
quantitative variables like age, blood sugar, cholesterol,
BMI, etc. Mean ± SD or Median (IQR) was calculated for
the aforementioned quantitative variables depending on
the normality assumption. Analysis of variance (ANOVA)
or Kruskil Wallis test was applied to compare the quanti-
tative variables among various groups (no kidney disease,
mild kidney disease and moderate kidney disease) as ap-
propriate. Chi-square test was used to check association
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genic, cyst, loss of CMD, stone etc. and various groups.
Multinomial regression
Initially participants were categorized into those having
no kidney disease, mild kidney disease and moderate
kidney disease. Both univariate and multivariable multi-
nomial regression analyses were performed to assess the
correlation of various factors that were significant in uni-
variate analysis with the outcome variable (no kidney dis-
ease, mild kidney disease and moderate kidney disease).
Binary logistic regression
However, due to the samll number of study participants
with mild and moderate kidney disease, we decided to
dichotomize the participants into those with no kidney
disease and those with kidney disease. Both univariate
and multivariable binary logistic regression analyses were
performed. Multivariable binary logistic regression ana-
lysis was performed to assess the correlation among
both groups for various risk factors that turned out to
be significant in univariate analysis.
Ethical approval
This study was approved by the Institutional Review
Board (IRB) of Interactive Research and Development
(IRD). Written informed consent was obtained from all
participants.
Results
A total of 461 adults (15 years of age and older) took
part in the IHCC baseline survey. However, due to re-
fusal to give urine specimen, 111 of them (42 men and
69 women) did not have urinary microalbumin data and
their kidney disease status could not be classified. The
socio-economic statistics of those excluded were similarTable 1 Characteristics of study participants, by age, gender
< 30 years; n (%) 30–50 years; n (%)
Gender
Male 71 (42.30) 59 (35.10)
Female 133 (45.40) 120 (41.00)
No kidney disease Mild kidney disease
Gender
Male 100 (79.40) 14 (11.10)
Female 192 (85.70) 16 (7.10)
Age
< 30 years 137 (46.90) 15 (50.00)
30-50 years 124 (42.5) 6 (20.00)
> 50 years 31 (10.60) 9 (30.00)
*p value < 0.05, calculated by Chi-square test.
**p value < 0.0001, calculated by Chi-square test.to those who were included in the analysis. The kidney
disease status of the remaining 350 adults, 126 males
(mean age: 35.2 ± 16.7 years) and 224 females (mean age:
34.0 ± 14.2 years) were grouped into three categories: no
kidney disease, mild kidney disease and moderate kidney
disease. Mild kidney disease was defined as eGFR ≥60
ml/min with microalbuminuria ≥ 30 mg/dl whereas mod-
erate kidney disease was defined as eGFR <60 ml/min
(with or without microalbuminuria).
Prevalence of kidney disease and age & gender distribution
The overall prevalence of kidney disease was 16.6%
(58/350 participants) with 8.6% participants with mild
kidney disease and 8% with moderate kidney disease.
Age, not gender, was significantly associated with kidney
disease (p < 0.0001) (Table 1).
Characteristics of the study participants among the groups
The baseline characteristics of the participants are
shown in Table 2. The mean values observed for age,
systolic and diastolic blood pressures, serum creatinine,
blood sugar random, HbA1c and HDL cholesterol levels
were significantly different among the three groups.
In the 415 participants where serum creatinine was
available, the mean eGFR was 87.1 ml/min per 1.73 m2
(85.8 ± 23.5 ml/min per 1.73 m2 in males, and 87.8 ±
22.6 ml/min per 1.73 m2 in females). The eGFR distribu-
tion is shown in Figure 1.
Relationship between abnormal variables, family history,
lifestyle and kidney disease
The frequency with which diabetes and hypertension were
noticed among the participants differed significantly among
the three groups. However, dyslipidemia and abnormal
BMI did not differ among the groups (Table 3). A statisti-
cally larger proportion of women (26%) were hypertensiveand kidney disease status
> 50 years; n (%) Total cohort p value
0.04*38 (22.60) 168 (36)
40 (13.70) 293 (64)
Moderate kidney disease Total cohort p value
12 (9.50) 126 (36)
0.3
16 (7.10) 224 (64)
1 (10.60) 153 (43.70)
0.000**12 (30.00) 142 (40.60)
15 (53.60) 55 (15.70)
Table 2 Characteristics of study participants on basis of kidney disease status
No kidney disease Mild kidney disease Moderate kidney disease Total cohort p value
Age (years); Median (IQR) 30 (22–40)a 30 (19.75-54.25)b 52.5 (46–64.75)a,b,c 31 (22–43)
0.000**
n 292 30 28 350
BMI (kg/m2); Median (IQR) 21 (18.6-25.3)a 21.8 (18.5-27.4)b 23.9 (20.4-28.6)c 21.33 (18.64-25.5)
0.09
n 290 30 28 348
SBP (mmHg); Median (IQR) 118.7 (110.3-128.0)a 123.7 (109.6-130.0)b 133.0 (122.3-158.0)a,b,c 119.67 (110.67-129.67)
0.000**
n 291 30 28 349
DBP (mmHg); Median (IQR) 75.0 (69.0-82.3)a 77.5 (70.5-82.7)b 83.7 (73.9-96.4)a,c 75.7 (69.3-83.0)
0.004*
n 291 30 28 349
Creatinine (mg/dl); Median (IQR) 0.9 (0.8-1)a 0.9 (0.8-1.1)a,b 1.3 (1.12-1.48)a,c 0.9 (0.8-1.1)
0.000**
n 292 30 28 350
BSR (mg/dl); Median (IQR) 95 (87–106.25)a 98.5 (85.7-117.75)a,b 104.5 (91.5-141)a,c 96 (87–111)
0.03*
n 290 30 28 348
HBA1C (%); Median (IQR) 5.3 (4.8-5.8)a 5.8 (4.9-6.02)a,b 5.65 (4.82-6.07)a,c 5.4 (4.8-5.8)
0.03*
n 288 30 28 346
Total CL (mg/dl); Median (IQR) 155.5 (138–184)a 148.5 (128–177.25)b 164 (138.5-220.75)c 155 (137–184)
0.3
n 292 30 28 350
HDL (mg/dl); Median (IQR) 40 (35–45)a 37.5 (31.75-42)a,b 42 (37–45)a,c 40 (34–45)
0.03*
n 292 30 27 349
a, b & cshows the significance difference between the groups. If any two or more groups have the same letters, there is significant difference between the groups.
*p value < 0.05 and **p value < 0.0001, calculated using Kruskil Wallis test.
IQR: Interquartile range (25th percentile – 75th percentile).
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portion of women (9%) were smokers as compared to men
(18%) (Table 4).
Smoking was significantly associated with kidney dis-
ease. Study participants either smoked regularly (12.3%)
or were non-smokers (87.1%). Only three participants
stated they were irregular smokers and for the purposeFigure 1 Distribution of eGFR in study participants. The
histogram of eGFR from 415 study participants indicates a skewed
distribution of the group with mean eGFR of 87.4 with a standard
deviation of 22.9 mL/min/1.73 m2.of analysis were considered non-smokers. We did not find
a significant difference of water, salt and unsaturated fat
intake between the groups (Table 5).
A family medical history of diabetes and hypertension
was significantly associated with kidney disease (Table 6).
However, a medical history of dyslipidemia, coronary artery
disease, stroke, kidney stones, kidney failure, lower urinary
tract symptoms, facial puffiness and pedal edema did not
vary significantly among the three groups.
Potential risk factors for kidney disease
We conducted univariate multinomial logistic regression
analysis to determine parameters with a significant asso-
ciation with kidney disease (Table 7). Relationship with
kidney disease was checked for age, HBA1C, gender,
BSR, HDL, medical history of diabetes mellitus, medical
history of hypertension as well as smoking status. None
of the potential risk factors were statistically significant
for mild kidney disease. However, factors found to be
statistically significant in the moderate kidney disease
group included increasing age (OR 1.1, 95% CI: 1.07-1.13),
presence of diabetes (OR 3.0, 95% CI: 1.0-8.6), presence of
hypertension (OR 3.9, 95% CI: 1.8-8.7), and being a regu-
lar smoker (OR 5.2, 95% CI: 2.2-12.4). The final multivari-
able multinomial logistic regression was built including
only those factors that were statistically significant in
univariate analysis. In the final multivariable multinomial
Table 3 Frequency of abnormal variables on basis of kidney disease severity, n (%)
No kidney disease Mild kidney disease Moderate kidney disease Total cohort p value
Diabetes status
Diabetic 20 (6.80) 5 (16.70) 5 (17.90) 30 (8.60)
0.035*
Non-diabetic 272 (93.20) 25 (83.30) 23 (82.10) 320 (91.40)
Hypertension status
Hypertensive 53 (18.20) 7 (23.30) 13 (46.40) 73 (20.90)
0.002*
Normotensive 239 (81.80) 23 (76.70) 15 (53.60) 277 (79.10)
Dyslipidemia status
Dyslipidemic 157 (53.80) 18 (60.00) 15 (53.60) 190 (54.30)
0.8
Non-dyslipidemic 135 (46.20) 12 (40.00) 13 (46.40) 160 (45.70)
Body mass index (BMI), kg/m2
Underweight BMI < 18.5 kg/m2 79 (24.1) 7 (23.3) 5 (17.9) 82 (23.6)
0.9
Normal BMI 18.5-24.9 kg/m2 146 (50.3) 13 (43.3) 13 (46.4) 172 (49.4)
Overweight (BMI 25.0-29.9 kg/m2 54 (18.6) 7 (23.3) 7 (25.0) 68 (19.5)
Obese BMI ≥ 30 kg/m2 20 (6.9) 3 (10.0) 3 (10.7) 26 (7.5)
*p value < 0.05; calculated by Chi-square test.
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95 CI: 1.05–1.12).
However, due to a paucity in the numbers of study
participants with mild and moderate kidney disease,
further analysis was done by dichotomizing kidney disease
into two categories, i.e. those without kidney disease and
those with kidney disease. Multivariate binary logistic
regression was used to build models to explain the pres-
ence of kidney disease. Variables found significant at
the univariate level or those with known biologically
significance with kidney disease were used. Potential
interaction between hypertension and smoking; hyper-
tension and diabetes; as well as smoking and diabetes
were explored. All interaction terms were found to be
statistically significant and used accordingly in the models
(Table 8). Three models were built with model 1 assessing
the association between kidney disease, hypertension and
smoking; model 2 assessing the association between kidneyTable 4 Frequency of abnormal variables on the basis of
gender
Male Female Total cohort p value
Diabetes status
Diabetic 16 (10.4) 23 (8.5) 39 (9.2)
0.6
Non-diabetic 138 (89.6) 249 (91.5) 387 (90.8)
Hypertension status
Hypertensive 27 (16.4) 75 (26) 102 (22.5)
0.02*
Normotensive 138 (83.6) 214 (74) 352 (77.5)
Smoking status
Smokers 30 (18) 26 (9.0) 56 (12.3) 0.007*
Non-smokers 137 (82) 264 (91.0) 401 (87.7)
*p value < 0.05; calculated by Chi-square test.disease, hypertension and diabetes and model 3 assessing
the association between kidney disease, smoking and
diabetes (Table 9). Age was dichotomized into under
40 years and 40 years and above in keeping with biological
significance.
Model 1- Effect of hypertension and smoking on kidney
disease: The odds of older participants having kidney
disease was a little over 3 times that of younger parti-
cipants (aOR 3.2, 95% CI: 1.7-6.0) and of the odds of
hypertensive smokers was almost five times that of par-
ticipants who were normotensive and never smoked.
(aOR 4.8 95% CI: 1.1-20.3); after adjusting for gender.
Model 2- Effect of hypertension and diabetes on kidney
disease: The odds of kidney disease among hypertensive,
non-diabetic participants was twice that of normotensive
non-diabetics (aOR 2.2; 95% CI: 1.1-4.5); and over 6 times
for hypertensive diabetic (aOR 6.4; 95% CI: 2.0-20.5),
while adjusting for gender.
Model 3- Effect of smoking and diabetes on kidney dis-
ease: In the presence of diabetes, smoking status, age and
gender, age was the only factor with a statistically significant
association with kidney disease (aOR 3.4; 95% CI 1.8-6.3).
Discussion
This is the first published study from Pakistan which has
diagnosed kidney disease using albuminuria in addition
to serum creatinine. Previous studies [10] have only used
creatinine in their diagnosis.
Our study found the overall prevalence of kidney dis-
ease to be 16.6% with 8% participants having moderate
kidney disease and 8.6% with mild kidney disease. In
Karachi, a large metropolitan city of over 20 million
people, two earlier community based surveys attempted
to look at the prevalence of kidney disease. The first
Table 5 Relationship between life style and kidney disease status
No kidney disease Mild kidney disease Moderate kidney disease Total cohort p value
Smoking status
Regular smoker 28 (9.60) 3 (100) 10 (35.70) 41 (11.70)
0.000**
Non-smoker 264 (90.40) 27 (90.00) 18 (64.30) 309 (88.30)
Water intake
Scanty, < 6 glasses a day 76 (26.00) 8 (23.30) 13 (46.40) 96 (27.40)
0.06
Adequate 216 (74.00) 23 (76.70) 15 (53.60) 254 (72.60)
Habit of adding salt
Yes 74 (25.30) 5 (16.70) 6 (21.40) 85 (24.30)
0.5
No 218 (74.70) 25 (83.30) 22 (78.60) 265 (75.70)
Unsaturated fat intake
Yes 76 (26.0) 4 (13.30) 6 (21.40) 86 (24.60)
0.3
No 216 (74.0) 26 (86.70) 22 (78.60) 264 (75.40)
**p value < 0.0001, calculated by Chi-square test.
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the same ethnic background and found a reduced
GFR prevalence of 29.9% (defined as creatinine clear-
ance <60 ml/min per 1.73 m2 measured in 24-hour
urine collection) [11]. The other survey of 300 adults
30 years or older found that 25.3% had some degree
of reduced eGFR based on serum creatinine, with 5%Table 6 Relationship between family medical history and kid
No kidney disease Mild kidney dise
Diabetes
Family history 58 (19.90) 7 (23.30)
No family history 233 (80.10) 23 (76.70)
Hypertension
Family history 95 (32.60) 12 (40.00)
No family history 196 (67.40) 18 (60.00)
Dyslipidemia
Family history 7 (2.40) 1 (3.30)
No family history 284 (97.60) 29 (96.70)
Coronary artery disease
Family history 39 (13.40) 3 (100)
No family history 252 (86.60) 27 (90.00)
Stroke
Family history 27 (9.30) 3 (100)
No family history 264 (90.70) 27 (90.00)
Kidney stones
Family history 39 (13.40) 3 (100)
No family history 252 (86.60) 27 (90.00)
Kidney failure
Family history 14 (4.80) 1 (3.30)
No family history 277 (95.20) 29 (96.70)
*p value < 0.05; calculated by Chi-square test.having eGFR <60 ml/min [10]. However, both these
studies had not taken albuminuria into account which
our study was able to do. An important study from
Bangladesh involving 1000 participants from 15 to
65 years age, classified them on the basis of eGFR by
MDRD equation and proteinuria on dipstick. The study
found an overall CKD prevalence of 13.1% of which 6.6%ney disease status of study participant
ase Moderate kidney disease Total cohort p value
0 (0.00) 65 (18.60)
0.03*
28 (100) 284 (81.40)
3 (10.70) 110 (31.50)
0.03*
25 (89.30) 239 (68.50)
0 (0.00) 8 (2.30)
0.7
28 (100) 341 (97.70)
0 (0.00) 42 (12.00)
0.1
28 (100) 307 (88.00)
0 (0.00) 30 (8.60)
0.2
28 (100) 319 (91.40)
2 (7.10) 44 (12.60)
0.6
26 (92.90) 305 (87.40)
0 (0.00) 15 (4.30)
0.5
28 (100) 334 (95.70)
Table 7 Univariate and multivariable risk factors for kidney disease status using multinomial regression
Variables
Mild kidney disease Moderate kidney disease
Prevalence odds ratio (95% CI) p value Prevalence odds ratio (95% CI) p value
UNIVARIATE
Age, yrs 1.02 (0.99-1.04) 0.22 1.1 (1.07-1.13) 0.000**
Diabetes mellitus status
Diabetic 2.7 (0.9-7.8) 0.07 3.0 (1.02-8.61) 0.047*
Non-diabetic Ref Ref
Hypertension status
Hypertensive 1.4 (0.6-3.4) 0.49 3.9 (1.8-8.7) 0.001*
Normotensive Ref Ref
Smoking status
Regular smoker 1.05 (0.3-3.7) 0.94 5.2 (2.2-12.4) 0.000**
Non-smoker Ref Ref
Gender
Male 1.7 (0.8-3.6) 0.18 1.4 (0.7-3.2) 0.4
Female Ref Ref
HDL 1.011 (0.97-1.06) 0.62 0.95 (0.89-1.01) 0.09
MULTIVARIABLE Adj POR (95% CI) p value Adj POR (95% CI) p value
Age, yrs 1.01 (0.98-1.04) 0.49 1.08 (1.05-1.12) 0.000**
Diabetes mellitus status
Diabetic 2.0 (0.4-9.6) 0.4 0.78 (0.16-3.9) 0.77
Non-diabetic Ref Ref
Hypertension status
Hypertensive 1.08 (0.4-2.9) 0.9 1.6 (0.6-4.1) 0.4
Normotensive Ref Ref
Smoking status
Regular smoker 0.9 (0.2-3.3) 0.9 2.6 (0.9-7.1) 0.07
Non-smoker Ref Ref
The reference category is: absence of kidney disease.
*p value < 0.05; **p value < 0.0001 calculated by multinomial logistic regression.
Abbreviation: POR Prevalence Odds Ratio.
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an eGFR <60 ml/min [17]. This trend is similar to what
we found in our study. Recently in Iran [18] and Thailand,
[19] the overall prevalence of CKD was found to be
19.52% and 17.5% respectively with 10.63% and 8.9%
having an eGFR ≥60 ml/min and an abnormal urine sedi-
ment while 8.89% and 8.6% with eGFR <60 ml/min. Simi-
larly, the prevalence of CKD, (eGFR of <60 ml/ min), was
found to be 8.4% in Japan [20] and 5.7% in Saudi Arabia
[21]. Serial cross-sectional surveys over the last three
decades demonstrate an increase in the prevalence of
CKD [22-24]. Although the variation in CKD prevalence
indicates differences between populations studied, an
important contributor maybe the differences in calibration
of serum creatinine assays and a lack of standardization
across laboratories.Our study found an overall estimated GFR of 87.1 ml/
min per 1.73 m2 among all study participants, women
were found to have a slightly higher eGFR. Moreover,
only 40.6% of all participants had eGFR ≥90 ml/min per
1.73 m2 and only 10% had eGFR ≥120 ml/min per
1.73 m2. This is an interesting finding and necessitates
studies aimed at validation of GFR in this particular
population. Based on our findings, there is a possibility
that “normal” values of GFR in our local population may
be lower from those calculated in western countries.
In our study, gender was not found to be significantly
associated with kidney disease. Earlier literature in this re-
gard has shown variable results. Some studies [17,19-21]
had not found a significant association between gender
and CKD while others [3,24-26] found CKD to be signi-
ficantly associated with the female gender. Interestingly
Table 8 Univariate analyses of risk factors for kidney







Age (for every 1 year increase in age) 1.05 (1.03-1.07) 0.000**
Age groups
40+ 4.0 (2.2-7.2) 0.000**
≤ 39 Ref
HDL 0.96 (0.9-0.99) 0.03*
Gender
Male 1.6 (0.9-2.8) 0.13
Female Ref
Diabetes mellitus status
Diabetic 2.8 (1.3-6.4) 0.01*
Non-diabetic Ref
Hypertension status
Hypertensive 2.3 (1.3-4.4) 0.006*
Normotensive Ref
Smoking status





Normotensive & smoker 2.4 (0.98-5.8) 0.054
Hypertension & non-smoker 2.2 (1.097-4.4) 0.03*
Hypertension & smoker 8.9 (2.3-35.2) 0.002*
Normotensive & non-smoker Ref
Hypertension and diabetes
mellitus interaction
Normotensive & diabetic 2.0 (0.6-6.6) 0.2
Hypertension & non-diabetic 2.0 (1.006-4.1) 0.048*
Hypertension & diabetic 5.7 (1.8-18.0) 0.003*
Normotensive & non-diabetic Ref|
Diabetes mellitus and smoking
interaction
Non-diabetic & smoker 2.6 (1.2-5.8) 0.02*
Diabetic & non-smoker 2.7 (1.1-6.9) 0.04*
Diabetic & smoker 6.5 (1.3-33.4) 0.03*
Non-diabetic & non-smoker Ref
a. The reference category is: absence of kidney disease.
*p value < 0.05; **p value < 0.0001 calculated by binary logistic regression.
Abbreviations are: CI-Confidence Interval, Ref-reference.
Table 9 Multivariable analyses of risk factors for kidney
disease using logistic regression; three explanatory models
Models
Kidney diseasea
aPOR (95% CI) P value
Model 1:
Age groups
40+ yrs 3.2 (1.7-6.0) 0.000**
<=39 Ref
Smoking and hypertension status
Normotensive AND smoker 1.6 ( 0.6-4.0) 0.35
Hypertensive AND non smoker 1.5 ( 0.7-3.2) 0.28
Hypertensive AND smoker 4.8 ( 1.1-20.3) 0.034**
Normotensive AND non smoker Ref
Gender
Male 1.6 (0.8-3.0) 0.11
Female Ref
Model 2:
Diabetes and hypertension status
Normotensive AND diabetic 1.9 (0.58-6.2) 0.29
Hypertensive AND non diabetic 2.2 (1.1-4.5) 0.03*
Hypertensive AND diabetic 6.4 (2.0-20.5) 0.002*
Normotensive AND non diabetic Ref
Gender




40+ yrs 3.4 (1.8-6.3) 0.000**
<=39 Ref
Diabetes and smoking status
Non diabetic AND smoker 1.8 (0.7-4.2) 0.2
Diabetic AND non smoker 1.6 (0.6-4.4) 0.3
Diabetic AND smoker 3.1 (0.6-16.4) 0.2
Non diabetic AND non smoker Ref
Gender
Male 1.5 (0.8-2.8) 0.2
Female Ref
a. The reference category is: No Kidney Disease.
*p value < 0.05; **p value < 0.0001 calculated by logistic regression.
Abbreviations are: CI-Confidence Interval, Ref-reference.
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disease and smoking are more prevalent in males and are
unlikely to explain the difference in CKD prevalence
between genders. The gender disparity might partly be theresult of an inaccurate correction factor for females in
the GFR estimating equation or due to the differences in
glomerular structure, glomerular homodynamics, diet,
production and activity of local cytokines and hormones,
and/or the direct effect of sex hormones, between genders
[27]. Further investigation into the contribution of gender
to CKD is required.
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factor in our study. Several studies performed in elderly
populations have shown the prevalence of CKD to be
more than 20% [28-31]. In general, GFR declines by
1 ml/min/1.73 m2 per year after the age of 30 years in
healthy persons and the steep increase in the prevalence
of CKD in the elderly might also be partly due to co-
morbidities of CKD, such as cardiovascular diseases or
diabetes, however, it is still unclear whether the decline
in kidney function with increasing age represents path-
ology or is a part of the normal ageing process [32].
The present study showed that diabetes and hyperten-
sion were significantly more frequent in patients with
kidney disease, however, dyslipidemia and abnormal BMI
did not differ significantly among the study groups.
Almost all the studies have shown similar trends with
respect to diabetes and hypertension, but association of
dyslipidemia and abnormal BMI with CKD is unclear.
Studies from Japan [20,23] and Iran [26] have shown a
strong association of these risk factors while other studies
from Bangladesh [17], Iran [18], Thailand [19], and Saudi
Arabia [21] have failed to show significant association in
this regard. We feel as dyslipidemia and abnormal BMI
are also associated with diabetes and hypertension, there-
fore, determining their association with CKD independent
of these diseases may not be easy.
We could not find significant association between kidney
disease and family histories of dyslipidemia, coronary ar-
tery disease, stroke, kidney stones, kidney failure, lower
urinary tract symptoms, facial puffiness and pedal edema.
A probable explanation of this might be the limitation of
our study that all medical histories were self-reported. On
the other hand, smoking, again self-reported was signi-
ficantly associated with kidney disease in our study. The
role of smoking as a risk factor for kidney disease is being
increasingly recognized and similar findings have been
noticed in our neighborhood Bangladesh [17]. Factors
such as quantity of cigarettes being smoked need to be
standardized to establish the association of smoking with
CKD as an independent risk factor.
Finally, there was low awareness found in the general
population with respect to non-communicable diseases
like diabetes, hypertension and chronic kidney disease.
This necessitates screening programs to be launched for
early recognition and prevention of complications of these
diseases, especially targeting CKD in high-risk popula-
tions. A clinical prediction score model can be developed
to help in identifying high-risk populations.
Study limitations
We were not able to use the term “chronic” kidney dis-
ease in describing out population since it is not possible
to evaluate chronicity based on a single assessment. The
definition of kidney disease used in the present paperwas derived from the definition of Chronic Kidney
Disease (CKD) first defined in 2002 Kidney Disease
Outcome Quality Initiative (K/DOQI) Guidelines [33], and
subsequently endorsed with minor modifications at the
Kidney Disease: Improving Global Outcomes (KDIGO)
Controversies Conference [34,35].
The glomerular filtration rate is ideally calculated through
the measurement of urinary clearance of an ideal filtration
marker such as insulin but is quite complex, expensive and
difficult to perform in cohort studies. Therefore, we used
an abbreviated version of the Modification of Diet in Renal
Disease (MDRD) formula [36] to estimate GFR.
For evaluation of albuminuria, we measured micro-
albumin in a spot urinary sample and used a cut-off
of ≥30 mg/dl to define albuminuria. In a recent update
of CKD classification by KDIGO, [37] albuminuria has
now been defined as an AER of ≥30 mg/24 hours
(ACR≥30 mg/g [≥3 mg/mmol]) which is greater than three
times the normal value in young adult men and women.
Measurement of albumin to creatinine ratio (ACR) in
a spot urinary sample was not possible in our study
because of cost implications. Consequently, we cate-
gorized kidney disease into Moderate Kidney Disease
with eGFR <60 ml/min irrespective of the level of protein-
uria and Mild Kidney Disease with eGFR ≥60 ml/min and
microalbuminuria ≥30 mg/dl in a spot urinary sample.
Conclusion
Overall, this is the first published study from Pakistan
that has diagnosed kidney disease using albuminuria in
addition to serum creatinine. The burden of kidney
disease in this population is found noteworthy and com-
parable to what have been seen in other developing
countries of this region. We believe that these results
have critical implications on health and economics of
these countries. The rapid rise of common risk factors
such as diabetes, hypertension and smoking especially
among the poor, will result in even greater and more
profound burdens that developing nations are not pres-
ently equipped to deal with. Moreover, there is a need to
monitor risk factors and disease trends through longitu-
dinal research. In conclusion, we feel there is a critical
need for funding in developing countries to implement
future community surveys followed by comprehensive,
cost-effective and preventive public health intervention
programs targeting chronic kidney disease.
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